Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 165.60
Ask: 166.00
Change: -2.80 (-1.67%)
Spread: 0.40 (0.242%)
Open: 165.20
High: 167.00
Low: 164.00
Prev. Close: 167.80
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

13 Oct 2014 07:00

RNS Number : 0489U
Essentra plc
13 October 2014
 



13 October 2014

 

ESSENTRA PLC

("Essentra" or "the Company")

A leading international supplier of speciality plastic, fibre, foam & packaging components

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1ST JULY 2014

STRONG REVENUE GROWTH MAINTAINED IN Q3

ON TRACK TO EXCEED VISION 2015 OBJECTIVES

 

 

Company Financial Performance

In the third quarter of 2014, revenue increased 8% versus Q3 2013 at constant exchange rates: on a like-for-like basis ("LFL"1) growth was +7%.

Divisional Overview (at Constant Exchange)

Revenue versus comparable period

 

Q3 2014

% change

Year-to-date 2014

% change

Component & Protection Solutions

- LFL

+17

+10

+15

+8

Porous Technologies2

- LFL

-9

-7

-9

-7

Packaging & Securing Solutions

- LFL

+2

+6

+28

+2

Filter Products

+11

+18

Other3

+13

+12

Total Company

- LFL

+8

+7

+16

+8

1 Like-for-like revenue is adjusted to exclude the impact of acquisitions, disposals and foreign exchange, but includes the impact of

Dakota Packaging Limited as it is no longer separately identifiable having been fully integrated into the healthcare packaging business

2 Includes intercompany revenue

3 Other relates to the Essentra Extrusion business

The result in Component & Protection Solutions was led by a strong performance in Pipe Protection Technologies, supported by continued improvement in the Components businesses in Europe and Asia: it was also boosted by the acquisitions of Mesan Kilit A.S. and Kelvindale Products Pty Ltd. In Porous Technologies, further good growth in speciality wipes and encouraging new business wins in air care were mitigated by softness in Printer Systems, notwithstanding the renewal of shipments to a major global OEM. Growth in Packaging & Securing Solutions came from healthcare packaging and speciality tapes, which outweighed weakness in tear tape to the tobacco market. Successful commercialisation of recent contract wins combined with ongoing proprietary innovation continued to underpin the result in Filter Products, with the increase in Extrusion benefiting from new business wins and a more encouraging European market backdrop.

There has been no material change in the financial position of the Company during the period.

On 24 September 2014, Essentra announced that it had signed an agreement for the acquisition of 100% of the share capital of the major operating subsidiaries of Abric Berhad ("Abric") for RM 146m (approximately £28m), on a cash free, debt free basis. The consideration, which is subject to customary adjustments for net debt and working capital, is payable on completion of the transaction and will be funded from the Company's existing facilities. Completion is subject to customary closing conditions, including certain regulatory clearances and approval from Abric's shareholders at an Extraordinary General Meeting, which are anticipated to be satisfied during the fourth quarter of 2014.

Commenting on today's Interim management Statement, Colin Day, Chief Executive, said:

"As Essentra's Vision 2015 approaches its conclusion, our year-to-date revenue growth of 8% on a like-for-like basis underscores that we remain on track to exceed our objectives of at least mid single-digit like-for-like revenue growth and double-digit adjusted EPS growth at constant exchange - not only in 2014, but also over the three-year period since the strategy was implemented.

Combined with continued good progress with the integration of recent acquisitions, as well as the successful transition to our new organisational structure, the Company is therefore also well-positioned for the next phase of its development, further details of which we will provide at our previously announced Capital Markets Day on 20 November."

The Company will hold a conference call to discuss this Interim Management Statement at 08:30 (UK time) today, details of which are as follows:

Dial-in number:

+44 (0)20 3428 1542 (UK / international participants)

+1 718 873 9077 (US participants)

Toll-free number:

0808 237 0040 (UK participants)

+1 866 928 7517 (US participants)

PIN code:

19606588#

Replay number:

+44 (0)20 3426 2807 (UK / international participants)

Toll-free number:

0808 237 0026 (UK participants)

+1 866 535 8030 (US participants)

Replay PIN

650898#

Replay available:

For 30 days

 

For Reference

The table below sets out Essentra's Q3 and year-to-date revenue growth by division at actual exchange rates.

Revenue vs comparable period

Q3 2014

% change

Year-to-date 2014

% change

Component & Protection Solutions

- LFL1

+10

+3

+8

+2

Porous Technologies2

- LFL

-15

-13

-15

-13

Packaging & Securing Solutions

- LFL

-1

+3

+24

-1

Filter Products

+1

+7

Other3

+9

+7

Total Company

- LFL

+1

+1

+8

+1

1 Like-for-like revenue is adjusted to exclude the impact of acquisitions, disposals and foreign exchange, but includes the impact of

Dakota Packaging Limited as it is no longer separately identifiable having been fully integrated into the healthcare packaging business

2  Includes intercompany revenue

3 Other relates to the Essentra Extrusion business

 

Enquiries

Essentra plc

Joanna Speed, Corporate Affairs Director

Tel: +44 (0)1908 359100

Buchanan

Richard Oldworth

Jeremy Garcia

Helen Chan

Tel: +44 (0)20 7466 5000

 

Notes to Editors

Essentra plc is a FTSE 250 company and a leading international supplier of speciality plastic, fibre, foam and packaging products. Through its four principal operating divisions, Essentra focuses on the light manufacture and distribution of high volume, essential components which serve customers in a wide variety of end-markets and geographies.

 

Component & Protection Solutions

The Components business is a global market leading manufacturer and distributor of plastic injection moulded, vinyl dip moulded and metal items. Operating units in 26 countries serve a very broad industrial base of customers with a rapid supply of primarily plastic products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics and construction.

 

The Pipe Protection Technologies business specialises in the manufacture of high performance innovative products from commodity resins to engineering-grade thermoplastics and polymer alloys for use in a range of end-markets. Locations in four countries, combined with a wide distributor network, serve customers around the world.

 

Porous Technologies

A global market leading developer and manufacturer of custom fluid handling components, engineered from a portfolio of technologies that includes bonded and non-woven fibre, polyurethane foam and porous plastic. Representing leading innovations used in healthcare, consumer and industrial applications, its enabling components are found in a wide range of products from medical diagnostics tests to advanced wound care pads, inkjet printer cartridges, writing instruments, clean room wipes and air fresheners. Customers in over 56 countries are served from six manufacturing facilities with research and development centres supporting the division globally.

 

Packaging & Securing Solutions

A leading global provider of packaging and securing solutions to a diversified blue-chip customer base. The division focuses on delivering value adding innovation, quality and service to customers through a range of cartons, tapes, leaflets, foils and labels for the healthcare, consumer and specialist packaging, point of sale and paper & board industries. The division is also a leading supplier of authentication technologies and identity solutions. Customers in over 100 countries are served from facilities operating in ten countries.

 

Filter Products

The only global independent cigarette filter supplier. The nine worldwide locations, including a UK-based research facility and three regional development centres provide a flexible infrastructure strategically positioned to serve the tobacco industry. The division supplies a wide range of value adding high quality innovative filters, packaging solutions to the roll your own sector and analytical laboratory services for ingredient measurement for the industry.

 

Other

The Extrusion business is a leading custom profile extruder located in The Netherlands and offers a complete design and production service. One of the first companies to extrude plastics in 1956, it is now one of Europe's most advanced suppliers of co-extrusions and tri-extrusions to all branches of industry.

 

Headquartered in the United Kingdom, Essentra's global network extends to 33 countries and includes c. 5,700 employees, 42 principal manufacturing facilities, 64 sales & distribution operations and 5 research & development centres. For further information, please visit www.essentra.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMMBATMBTBBRI
Date   Source Headline
20th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 202411:50 amRNSTransaction in Own Shares
17th Jun 202411:43 amRNSHolding(s) in Company
13th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20244:26 pmRNSHolding(s) in Company
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20247:00 amRNSTransaction in Own Shares
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSDirector/PDMR Shareholding
24th May 202411:21 amRNSResult of AGM
24th May 202410:26 amRNSAGM Statement
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSBoard Appointment - Chair Designate
23rd May 20247:00 amRNSAGM Trading Update
21st May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 202411:32 amRNSTransaction in Own Shares
3rd May 202411:26 amRNSTransaction in Own Shares - Correction
3rd May 202411:17 amRNSTransaction in Own Shares - Correction
3rd May 202411:12 amRNSTransaction in Own Shares - Correction
3rd May 202411:06 amRNSTransaction in Own Shares - Correction
3rd May 202411:02 amRNSTransaction in Own Shares - Correction
3rd May 202410:58 amRNSTransaction in Own Shares - Correction
3rd May 202410:53 amRNSTransaction in Own Shares - Correction
3rd May 202410:46 amRNSTransaction in Own Shares - Correction
3rd May 202410:36 amRNSTransaction in Own Shares - Correction
3rd May 202410:26 amRNSTransaction in Own Shares
3rd May 202410:22 amRNSTransaction in Own Shares - Correction
3rd May 202410:06 amRNSTransaction in Own Shares - Correction
3rd May 20249:59 amRNSTransaction in Own Shares - Correction
3rd May 20249:54 amRNSTransaction in Own Shares - Correction
3rd May 20249:47 amRNSTransaction in Own Shares - Correction
3rd May 20249:30 amRNSTransaction in Own Shares - Correction
2nd May 20249:44 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 20247:45 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20241:57 pmRNSDirector/PDMR Shareholding
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20242:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.